| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SLC8A1_0025500 | Exon-Exon | chr2:40656539-40656717 | chr2:40429399-40429577 | 179 nt | 0.4358 |
| hsa_SLC8A1_0027600 | Intron-Intron | chr2:40762099-40787973 | chr2:40534959-40560833 | 250 nt | 0.3240 |
| hsa_AC007377.1_0000100 | Intergenic-Exon-Intergenic | chr2:40486353-40512002 | chr2:40259213-40284862 | 250 nt | 0.3480 |
| hsa_AC007377.1_0000100 | Intergenic-Exon-Intergenic | chr2:40486353-40512002 | chr2:40259213-40284862 | 250 nt | 0.3480 |
| hsa_AC007377.1_0000100 | Intergenic-Exon-Intergenic | chr2:40486353-40512002 | chr2:40259213-40284862 | 250 nt | 0.3480 |
| hsa_SLC8A1_0000300 | Exon-Exon | chr2:40325863-40326058 | chr2:40098723-40098918 | 196 nt | 0.2857 |
| hsa_SLC8A1_0000400 | Exon-Exon | chr2:40338321-40392124 | chr2:40111181-40164984 | 250 nt | 0.3520 |
| hsa_SLC8A1_0000600 | Exon-Intron | chr2:40338321-40397489 | chr2:40111181-40170349 | 300 nt | 0.4767 |
| hsa_SLC8A1_0000700 | Exon-Exon | chr2:40340698-40340944 | chr2:40113558-40113804 | 247 nt | 0.4170 |
| hsa_SLC8A1_0000800 | Exon-Exon | chr2:40341348-40341571 | chr2:40114208-40114431 | 224 nt | 0.4554 |
A study in rats and H9c2 cells demonstrated that the circSLC8A1 is upregulated in ischemic heart disease models [Tian et al. DOI:10.1038/s41598-021-84056-5]. Furthermore, research in human peripheral blood confirmed the circSLC8A1 is significantly upregulated in myocardial infarction patients and exhibits high diagnostic value as a biomarker [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in mice demonstrated that the circSLC8A1 (mmu_circ_004295) is increased with ischemia time in the heart and promotes cardiomyocyte apoptosis by acting as an endogenous miR-133a-3p sponge [Tian et al. DOI:10.3390/molecules26041155].